Market Value124,433,786
Total Holdings72
File Date2024-02-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PAAS / Pan American Silver Corp.
BGC / BGC Group, Inc.
FEMY / Femasys Inc.
AVIR / Atea Pharmaceuticals, Inc.
PFE / Pfizer Inc.
XOMA / XOMA Royalty Corporation
DIT / AMCON Distributing Company
PLPC / Preformed Line Products Company
NHC / National HealthCare Corporation
RIGL / Rigel Pharmaceuticals, Inc.
EDSA / Edesa Biotech, Inc.
CLPT / ClearPoint Neuro, Inc.
TAST / Carrols Restaurant Group, Inc.
BCDA / BioCardia, Inc.
TRC / Tejon Ranch Co.
USAP / Universal Stainless & Alloy Products, Inc.
SFE / Safeguard Scientifics, Inc.
FIS / Fidelity National Information Services, Inc.
FNF / Fidelity National Financial, Inc.
VTLE / Vital Energy, Inc.
RNAC / Cartesian Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
AMSC / American Superconductor Corporation
NEUE / NeueHealth, Inc.
RLGT / Radiant Logistics, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
CHRS / Coherus Oncology, Inc.
GANX / Gain Therapeutics, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
SMSI / Smith Micro Software, Inc.
INTT / inTEST Corporation
NMRK / Newmark Group, Inc.
FCX / Freeport-McMoRan Inc.
PD / PagerDuty, Inc.
OGN / Organon & Co.
BRKL / Brookline Bancorp, Inc.
COYA / Coya Therapeutics, Inc.
TALO / Talos Energy Inc.
SVC / Service Properties Trust
HRTX / Heron Therapeutics, Inc.
ARKO / Arko Corp.
NWL / Newell Brands Inc.
VTRS / Viatris Inc.
FHN / First Horizon Corporation
KRON / Kronos Bio, Inc.
BCEL / Atreca, Inc.
SWN / Southwestern Energy Company
EDSA / Edesa Biotech, Inc.
VTOL / Bristow Group Inc.
DRRX / DURECT Corporation
WKC / World Kinect Corporation
APA / APA Corporation
CRIS / Curis, Inc.
WBD / Warner Bros. Discovery, Inc.
IOVA / Iovance Biotherapeutics, Inc.
GOLD / Barrick Mining Corporation
ARKR / Ark Restaurants Corp.
TGB / Taseko Mines Limited
CTSO / Cytosorbents Corporation
NKTR / Nektar Therapeutics
CGAU / Centerra Gold Inc.
CADE / Cadence Bank
RVNC / Revance Therapeutics, Inc.
CMPX / Compass Therapeutics, Inc.
RBCAA / Republic Bancorp, Inc.
LTRN / Lantern Pharma Inc.
ACAD / ACADIA Pharmaceuticals Inc.
FOLD / Amicus Therapeutics, Inc.
ALCO / Alico, Inc.
WBA / Walgreens Boots Alliance, Inc.
KD / Kyndryl Holdings, Inc.
PK / Park Hotels & Resorts Inc.
ELTX / Elicio Therapeutics, Inc.
SABR / Sabre Corporation
RPRX / Royalty Pharma plc
ASRT / Assertio Holdings, Inc.
BATL / Battalion Oil Corporation
EOLS / Evolus, Inc.